Related references
Note: Only part of the references are listed.BRCA1/2 testing: uptake, phenocopies, and strategies to improve detection rates in initially negative families
C. Fischer et al.
CLINICAL GENETICS (2012)
Identification of BRCA1-deficient ovarian cancers
Anne-Bine Skytte et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2011)
HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition
Karuppaiyah Selvendiran et al.
CANCER BIOLOGY & THERAPY (2011)
PARP Inhibitors in BRCA Gene-Mutated Ovarian Cancer and Beyond
Susana Banerjee et al.
CURRENT ONCOLOGY REPORTS (2011)
Cellular uptake, retention and bioabsorption of HO-3867, a fluorinated curcumin analog with potential antitumor properties
Alex Dayton et al.
CANCER BIOLOGY & THERAPY (2010)
Safe and targeted anticancer efficacy of a novel class of antioxidant-conjugated difluorodiarylidenyl piperidones: Differential cytotoxicity in healthy and cancer cells
Karuppaiyah Selvendiran et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
SGO White Paper on Ovarian Cancer: Etiology, Screening and Surveillance
John O. Schorge et al.
GYNECOLOGIC ONCOLOGY (2010)
HO-3867, a Synthetic Compound, Inhibits the Migration and Invasion of Ovarian Carcinoma Cells through Downregulation of Fatty Acid Synthase and Focal Adhesion Kinase
Karuppaiyah Selvendiran et al.
MOLECULAR CANCER RESEARCH (2010)
Anticancer Efficacy of a Difluorodiarylidenyl Piperidone (HO-3867) in Human Ovarian Cancer Cells and Tumor Xenografts
Karuppaiyah Selvendiran et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Loss of BRCA1 function increases the antitumor activity of cisplatin against human breast cancer xenografts in vivo
Pierfrancesco Tassone et al.
CANCER BIOLOGY & THERAPY (2009)
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Dunyaporn Trachootham et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Concomitant activation of the JAK/STAT3 and ERK1/2 signaling is involved in leptin-mediated proliferation of renal cell carcinoma Caki-2 cells
Lei Li et al.
CANCER BIOLOGY & THERAPY (2008)
Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: The national Israeli study of ovarian cancer
Angela Chetrit et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
EF24 induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by increasing PTEN expression
Karuppaiyah Selvendiran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer
Zhenfeng Duan et al.
CLINICAL CANCER RESEARCH (2006)
Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: An implication for the antitumor potential of flavonoids
Karuppaiyah Selvendiran et al.
CANCER RESEARCH (2006)
Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway
D Chirnomas et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Characterization of BRCA1 and BRCA2 mutations in a large United States sample
SN Chen et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Prospective strategies to enforce selectively cell death in cancer cells
MV Blagosklonny
ONCOGENE (2004)
The stats of cancer - New molecular targets come of age
H Yu et al.
NATURE REVIEWS CANCER (2004)
Oxidative stress, redox, and the tumor microenvironment
JA Cook et al.
SEMINARS IN RADIATION ONCOLOGY (2004)
Molecular functions of BRCA1 in the DNA damage response
R Scully et al.
CANCER BIOLOGY & THERAPY (2004)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies
A Antoniou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Effects of soy isoflavones on apoptosis induction and G2-M arrest in human hepatoma cells involvement of caspase-3 activation, Bcl-2 and BCI-X-L downregulation, and Cdc2 kinase activity
SJ Su et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2003)
Bcl-2-family proteins and the role of mitochondria in apoptosis
T Kuwana et al.
CURRENT OPINION IN CELL BIOLOGY (2003)
Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells
B Gao et al.
FEBS LETTERS (2001)
Bcl-2 family proteins as targets for anticancer drug design
ZW Huang
ONCOGENE (2000)
Constitutive activation of Stat 3 oncogene product in human ovarian carcinoma cells
M Huang et al.
GYNECOLOGIC ONCOLOGY (2000)
Clinicopathologic features of BRCA-linked and sporadic ovarian cancer
J Boyd et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
